Novel protein tyrosine phosphatase 1B inhibitors: Interaction requirements for improved intracellular efficacy in type 2 diabetes mellitus and obesity control

Biochemical and Biophysical Research Communications

Volumn 410, Issue 3, 2011, Pages 377-381

  Popov, Doina ^a  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

Author keywords

Obesity; PTP1B; Type 2 diabetes mellitus

Indexed keywords

BERBERINE; GLUCOSE; IMIDAZOLE DERIVATIVE; IMIDAZOLINE DERIVATIVE; INSULIN; JT 551; JTT 551; LEPTIN; LGH 00081; LZP 25; LZP 6; N [2 (4 METHOXYPHENYL) ETHYL] ACETAMIDE DERIVATIVE; P 28; PAPAVERINE; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR; SA 18; SA 32; UNCLASSIFIED DRUG; VANADIUM DERIVATIVE;

CONFORMATIONAL TRANSITION; DIABETES MELLITUS; DRUG BINDING SITE; DRUG EFFICACY; DRUG POTENCY; DRUG PROTEIN BINDING; ENZYME INHIBITION; ENZYME STRUCTURE; GLUCOSE BLOOD LEVEL; HYDROGEN BOND; INSULIN RESISTANCE; MEMBRANE PERMEABILITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; SIGNAL TRANSDUCTION;

DIABETES MELLITUS, TYPE 2; ENZYME INHIBITORS; HUMANS; INSULIN RESISTANCE; LEPTIN; MOLECULAR STRUCTURE; OBESITY; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1;

EID: 79960073235     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.06.009     Document Type: Short Survey

References (46)

1. Morris D.L., Rui L. Recent advances in understanding leptin signaling and leptin resistance. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E1247-E1259.
2. Elchebly M., Payette P., Michaliszyn E., et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 1999, 283:1544-1548.
3. Klaman L.D., Boss O., Peroni O.D., et al. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol. Cell. Biol. 2000, 20:5479-5489.
4. Ali M.I., Ketsawatsomkron P., Belin de Chantemele E.J., et al. Deletion of protein tyrosine phosphatase 1B improves peripheral insulin resistance and vascular function in obese, leptin-resistant mice via reduced oxidant tone. Circ. Res. 2009, 105:1013-1022.
5. Cheng A., Uetani N., Simoncic P.D., et al. Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev. Cell. 2002, 2:385-387.
6. Erbe D.V., Klaman L.D., Wilson D.P., et al. Prodrug delivery of novel PTP1B inhibitors to enhance insulin signaling. Diab. Obes. Metab. 2009, 11:579-588.
7. Park H., Bhattarai B.R., Ham S.W., et al. Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors. Eur. J. Med. Chem. 2009, 44:3280-3284.
8. Wang J.F., Gong K., Wei D.Q., et al. Molecular dynamics studies on the interactions of PTP1B with inhibitors: from the first phosphate-binding site to the second one. Protein Eng. Des. Sel. 2009, 22:349-355.
9. Picha K.M., Patel S.S., Mandiyan S., et al. The role of the C-terminal domain of protein tyrosine phosphatase-1B in phosphatase activity and substrate binding. J. Biol. Chem. 2007, 282:2911-2917.
10. González-Rodríguez Á., Mas Gutierrez J.A., Sanz-González S., et al. Inhibition of PTP1B restores IRS1-mediated hepatic insulin signaling in IRS2-deficient mice. Diabetes 2010, 59:588-599.
11. Hosoi T., Sasaki M., Miyahara T., et al. Endoplasmic reticulum stress induces leptin resistance. Mol. Pharmacol. 2008, 74:1610-1619.
12. Venkatesan B., Ghosh-Choudhury N., Das F., et al. Resveratrol inhibits PDGF receptor mitogenic signaling in mesangial cells: role of PTP1B. FASEB J. 2008, 22:3469-3482.
13. Zhuang D., Balani P., Pu Q., et al. Suppression of PKG by PDGF or nitric oxide in differentiated aortic smooth muscle cells: obligatory role of protein tyrosine phosphatase 1B. Am. J. Physiol. Heart Circ. Physiol. 2011, 300:H57-H63.
14. Juarez J.C., Manuia M., Burnett M.E., et al. Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling. Proc. Natl. Acad. Sci. USA 2008, 105:7147-7152.
15. Hsu M.-F., Meng T.-C. Enhancement of insulin responsiveness by nitric oxide-mediated inactivation of protein-tyrosine phosphatases. J. Biol. Chem. 2010, 285:7919-7928.
16. Yuan C., Lu L., Wu Y., et al. Synthesis, characterization, and protein tyrosine phosphatases inhibition activities of oxovanadium(IV) complexes with Schiff base and polypyridyl derivatives. J. Inorg. Biochem. 2010, 104:978-986.
17. McLauchlan C.C., Hooker J.D., Jones M.A., et al. Inhibition of acid, alkaline, and tyrosine (PTP1B) phosphatases by novel vanadium complexes. J. Inorg. Biochem. 2010, 104:274-281.
18. Song Z., He X.P., Li C., et al. Preparation of triazole-linked glycosylated (α-ketocarboxylic acid derivatives as new PTP1B inhibitors. Carbohydr. Res. 2011, 346:140-145.
19. Holmes C.P., Li X., Pan Y., et al. PTP1B inhibitors: synthesis and evaluation of difluoro-methylenephosphonate bioisosteres on a sulfonamide scaffold. Bioorg. Med. Chem. Lett. 2008, 18:2719-2724.
20. Kurundkara S.B., Sachanb N., Kodama K.M., et al. Antihyperglycemic activity of VMNS2E, a novel biphenyl PTP1B inhibitor and its effect on insulin resistance, diabetes and dyslipidemia. Diab. Vasc. Dis. Res. 2011, 8:91.
21. Lin L., Shen Q., Chen G.R., et al. Beta-C-glycosiduronic acids and beta-C-glycosyl compounds: new PTP1B inhibitors. Bioorg. Med. Chem. Lett. 2008, 18:6348-6351.
22. Gupta S., Pandey G., Rahuja N., et al. Design, synthesis and docking studies on phenoxy-3-piperazin-1-yl-propan-2-ol derivatives as protein tyrosine phosphatase 1B inhibitors. Bioorg. Med. Chem. Lett. 2010, 20:5732-5734.
23. Saxena A.K., Pandey G., Gupta S., et al. Synthesis of protein tyrosine phosphatase 1B inhibitors: model validation and docking studies. Bioorg. Med. Chem. Lett. 2009, 19:2320-2323.
24. Bhattarai B.R., Kafle B., Hwang J.-S., et al. Thiazolidinedione derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity effects. Bioorg. Med. Chem. Lett. 2009, 19:6161-6165.
25. Bhattarai B.R., Kafle B., Hwang J.S., et al. Novel thiazolidinedione derivatives with anti-obesity effects: dual action as PTP1B inhibitors and PPAR-γ activators. Bioorg. Med. Chem. Lett. 2010, 20:6758-6763.
26. Douty B., Wayland B., Ala P.J., et al. Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolines. Bioorg. Med. Chem. Lett. 2008, 18:66-71.
27. Shi L., Yu H.P., Zhou Y.Y., et al. Discovery of a novel competitive inhibitor of PTP1B by high-throughput screening. Acta Pharmacol. Sin. 2008, 29:278-284.
28. Liu S., Zeng L.F., Wu L., et al. Targeting inactive enzyme conformation: aryl diketoacid derivatives as a new class of PTP1B inhibitors. J. Am. Chem. Soc. 2008, 130:17075-17084.
29. Bharatham K., Bharatham N., Kwon Y.J., et al. Molecular dynamics simulation study of PTP1B with allosteric inhibitor and its application in receptor based pharmacophore modeling. J. Comput. Aid. Mol. Des. 2008, 22:925-933.
30. Ottana R., Maccari R., Ciurleo R., et al. 5-Arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors. Bioorg. Med. Chem. Lett. 2009, 17:1928-1937.
31. Ye D., Zhang Y., Wang F., et al. Novel thiophene derivatives as PTP1B inhibitors with selectivity and cellular activity. Bioorg. Med. Chem. Lett. 2010, 18:1773-1782.
32. Kumar R., Shinde R.N., Ajay D., et al. Probing interaction requirements in PTP1B inhibitors: a comparative molecular dynamics study. J. Chem. Inf. Model. 2010, 50:1147-1158.
33. Fang L., Zhang H., Cui W., et al. Studies of the mechanism of selectivity of protein tyrosine phosphatase 1B (PTP1B) bidentate inhibitors using molecular dynamics simulations and free energy calculations. J. Chem. Inf. Model. 2008, 48:2030-2041.
34. Townshend B., Aubry I., Marcellus R.C., et al. An RNA aptamer that selectively inhibits the enzymatic activity of protein tyrosine phosphatase 1B in vitro. Chembiochem. 2010, 11:1583-1593.
35. Chen C., Zhang Y., Huang C. Berberine inhibits PTP1B activity and mimics insulin action. Biochem. Biophys. Res. Commun. 2010, 397:543-547.
36. Bustanji Y., Taha M.O., Al-Masri I.M., et al. Docking simulations and in vitro assay unveil potent inhibitory action of Papaverine against protein tyrosine phosphatase 1B. Biol. Pharm. Bull. 2009, 32:640-645.
37. Liu Z., Chai Q., Li Y.Y., et al. Discovery of novel PTP1B inhibitors with antihyperglycemic activity. Acta Pharmacol. Sin. 2010, 31:1005-1012.
38. Fukuda S., Ohta T., Sakata S., et al. Pharmacological profiles of a novel protein tyrosine phosphatase 1B inhibitor, JTT-551. Diab. Obes. Metab. 2010, 12:299-306.
39. Bhattarai B.R., Lee K.-H., Cho H. Antihyperglycemic effects of methylenedisalicylic acid. Bull. Korean Chem. Soc. 2009, 30:2879-2880.
40. Bhattarai B.R., Ko J.-H., Shrestha S., et al. Inhibition of IKK-b: a new development in the mechanism of the anti-obesity effects of PTP1B inhibitors SA18 and SA32. Bioorg. Med. Chem. Lett. 2010, 20:1075-1077.
41. Muthusamy V.S., Saravanababu C., Ramanathan M., et al. Inhibition of protein tyrosine phosphatase 1B and regulation of insulin signalling markers by caffeoyl derivatives of chicory (Cichorium intybus) salad leaves. Br. J. Nutr. 2010, 104:813-823.
42. Li J.M., Li Y.C., Kong L.D., et al. Curcumin inhibits hepatic protein-tyrosine phosphatase 1B and prevents hypertriglyceridemia and hepatic steatosis in fructose-fed rats. Hepatology 2010, 51:1555-1566.
43. Muthusamy V.S., Anand S., Sangeetha K.N., et al. Tannins present in Cichorium intybus enhance glucose uptake and inhibit adipogenesis in 3T3-L1 adipocytes through PTP1B inhibition. Chem. Biol. Interact. 2008, 174:69-78.
44. Comeau A.B., Critton D.A., Page R., et al. A focused library of protein tyrosine phosphatase inhibitors. J. Med. Chem. 2010, 53:6768-6772.
45. Cheng Y., Zhou M., Tung C.H., et al. Studies on two types of PTP1B inhibitors for the treatment of type 2 diabetes: hologram QSAR for OBA and BBB analogues. Bioorg. Med. Chem. Lett. 2010, 20:3329-3337.
46. Baumgartner R.R., Steinmann D., Heiss E.H., et al. Bioactivity-guided isolation of 1,2,3,4,6-penta-O-galloyl-d-glucopyranose from Paeonia lactiflora roots as a PTP1B inhibitor. J. Nat. Prod. 2010, 73:1578-1581.